Clinical trial
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic…
NCT00136045 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00136045 |
|---|---|
| Title | Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome |
| Official title | A Multi-center, Randomized, Double-blind, Placebo-controlled, Four-arm Parallel-group Trial to Investigate the Efficacy and Safety of Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Rotigotine |
| Enrollment | 549 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Aug 26, 2005 |
| Last update posted | Sep 25, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: